Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein: Their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation

Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology

Volumn 1479, Issue 1-2, 2000, Pages 91-102

  Oyama, Rieko ^a,b   Yamamoto, Hirotaka ^c   Titani, Koiti ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Inst Compreh Med Sci   (Japan)

^c Chicago Institute of Neurosurgery and Neuroresearch   (United States)

Author keywords

A binding protein; Affinity chromatography; Alzheimer's disease; Amyloid protein; Immunoblot; Immunoprecipitation

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; GLUTAMATE AMMONIA LIGASE; HEMOGLOBIN ALPHA CHAIN; MACROPHAGE MIGRATION INHIBITION FACTOR;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SEQUENCE ANALYSIS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CHROMATOGRAPHY, AFFINITY; GLUTAMATE-AMMONIA LIGASE; HEMOGLOBINS; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PRECIPITIN TESTS; PROTEIN BINDING; RATS; RATS, WISTAR;

EID: 0034660602     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(00)00057-1     Document Type: Article

References (52)

1. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
2. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
3. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
4. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 331:1988;530-532.
5. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., Cordell B. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 331:1988;525-527.
6. Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L., Gusella J.F., Neve R.L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 331:1988;528-530.
7. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., Steven G., Younkin G. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
8. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
9. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
10. Shinkai Y., Yoshimura M., Morishima-Kawashima M., Ito Y., Shimada H., Yanagisawa K., Ihara Y. Amyloid β-protein deposition in the leptomeninges and cerebral cortex. Ann. Neurol. 42:1997;899-908.
11. Oyama F., Shimada H., Oyama R., Titani K., Ihara Y. β-Amyloid protein precursor and tau mRNA levels versus β-amyloid plaque and neurofibrillary tangles in the aged human brain. J. Neurochem. 60:1993;1658-1664.
12. Abraham C.R., Razzaboni B.L., Sisodia S.S., Koo E.H., Price D.L., Van Nostrand W.E., Papastoitsis G. Studies on the proteolytic degradation of the β-protein precursor by proteases purified from Alzheimer's disease brain. Ann. New York Acad. Sci. 640:1991;161-165.
13. Permanne B., Perez C., Soto C., Frangione B., Wisniewski T. Detection of apolipoprotein E/dimeric soluble amyloid β complexes in Alzheimer's disease brain supernatants. Biochem. Biophys. Res. Commun. 240:1997;715-720.
14. Barrow C.J., Yasuda A., Kenny P.T., Zagorski M.G. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225:1992;1075-1093.
15. Shen C.-L., Murphy R.M. Solvent effects on self-assembly of β-amyloid peptide. Biophys. J. 69:1995;640-651.
16. Garzon-Rodriguez W., Sepulveda-Becerra M., Milton S., Glabe C.G. Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272:1997;21037-21044.
17. Cuatrecasas P., Parikh I. Adsorbents for affinity chromatography. Use of N-hydroxysuccinimide esters of agarose. Biochemistry. 11:1972;2291-2299.
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
19. Walker J.M. The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol. Biol. 32:1994;5-8.
20. Ishiguro M., Takio K., Suzuki M., Oyama R., Matsuzawa T., Titani K. Complete amino acid sequence of human liver cytosolic alanine aminotransferase (GPT) determined by a combination of conventional and mass spectral methods. Biochemistry. 30:1991;10451-10457.
21. Hewick R.M., Hunkapiller M.W., Hood L.E., Dreyer W.J. A gas-liquid solid phase peptide and protein sequenator. J. Biol. Chem. 256:1981;7990-7997.
22. Mahoney W.C., Hermodson M.A. Separation of large denatured peptides by reverse phase high performance liquid chromatography. Trifluoroacetic acid as a peptide solvent. J. Biol. Chem. 255:1980;11199-11203.
23. Masaki T., Tanabe M., Nakamura K., Soejima M. Studies on a new proteolytic enzyme from Achromobacter lyticus M497-1. I. Purification and some enzymatic properties. Biochim. Biophys. Acta. 660:1981;44-50.
24. Wilbur W.J., Lipman D.J. Rapid similarity searches of nucleic acid and protein data banks. Proc. Natl. Acad. Sci. USA. 80:1983;726-730.
25. Bernhagen J., Mitchell R.A., Calandra T., Voelter W., Cerami A., Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry. 33:1994;14144-14155.
26. Whitehead T.P., Kricka L.J., Carter T.J., Thorpe G.H. Analytical luminescence: its potential in the clinical laboratory. Clin. Chem. 25:1979;1531-1546.
27. Yamamoto H., Konno H., Yamamoto T., Ito K., Mizugaki M., Iwasaki Y. Glutamine synthetase of the human brain: purification and characterization. J. Neurochem. 49:1987;603-609.
28. Pirttila T., Kim K.S., Mehta P.D., Frey H., Wisniewski H.M. Soluble amyloid β-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls. J. Neurol. Sci. 127:1994;90-95.
29. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
30. Ida N., Hartmann T., Pantel J., Schröder J., Zerfass R., Förstl H., Sandbrink R., Masters C.L., Beyreuther K. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 271:1996;22908-22914.
31. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
32. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
33. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
34. Joslin G., Krause J.E., Hershey A.D., Adams S.P., Fallon R.J., Perlmutter D.H. Amyloid-β peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. J. Biol. Chem. 266:1991;21897-21902.
35. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133:1988;456-463.
36. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
37. 1-antichymotrypsin. Neurobiol. Aging. 11:1990;123-129.
38. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
39. Schwarzman A.L., Gregori L., Vitek M.P., Lyubski S., Strittmatter W.J., Enghilde J.J., Bhasin R., Silverman J., Weisgraber K.H., Coyle P.K., Zagorski M.G., Talafous J., Eisenberg M., Saunders A.M., Roses A.D., Goldgaber D. Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl. Acad. Sci. USA. 91:1994;8368-8372.
40. Islam K., Levy E. Carboxyl-terminal fragments of β-amyloid precursor protein bind to microtubules and the associated protein tau. Am. J. Pathol. 151:1997;265-271.
41. Matsumoto A., Minami M., Matsumoto R. The β-amyloid epitope masking activity in human brain is identified as albumin. NeuroReport. 8:1997;3297-3301.
42. Schulze H., Schuler A., Stuber D., Dobeli H., Langen H., Huber G. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's β-amyloid precursor protein. J. Neurochem. 60:1993;1915-1922.
43. Gunnersen D., Haley B. Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker. Proc. Natl. Acad. Sci. USA. 89:1992;11949-11953.
44. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
45. Aksenov M., Aksenova M.V., Harris M.E., Hensley K., Butterfield D.A., Carney J.M. Enhancement of β-amyloid peptide Aβ (1-40)-mediated neurotoxicity by glutamine synthetase. J. Neurochem. 65:1995;1899-1902.
46. Bucala R. Identification of MIF as a new pituitary hormone and macrophage cytokine and its role in endotoxic shock. Immunol. Lett. 43:1994;23-26.
47. Eikelenboom P., Rozemuller J.M., Kraal G., Stam F.C., McBride P.A., Bruce M.E., Fraser H. Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 60:1991;329-336.
48. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., Cerami A., Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 377:1995;68-71.
49. Breitner J.C., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., Anthony J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 44:1994;227-232.
50. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
51. Zeng F.Y., Gerke V., Gabius H.J. Characterization of the macrophage migration inhibitory factor-binding site of sarcolectin and its relationship to human serum albumin. Biochem. Biophys. Res. Commun. 200:1994;89-94.
52. Russo C., Angelini G., Dapino D., Piccini A., Piombo G., Schettini G., Chen S., Teller J.K., Zaccheo D., Gambetti P., Tabaton M. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 95:1998;15598-15602.